Insulin Glulisine, Solution For Injection, 100 Units/Ml, 3 Ml Each; Insulin Glargine, Solution For Injection, 100 Units/Ml, 3 Ml Each; Insulin Degludec And Liraglutide, Solution For Injection, 100 Units/Ml And 3.6 Mg/Ml, 3 Ml Each; Insulin Detemir, Solution For Injection, 100 Units/Ml, 3 Ml Each; Insulin Aspart (Fast-Acting), Solution For Injection, 100 U/Ml, 3 Ml Each; Insulin Glargine, Solution For Injection, 300 Units/Ml, 1.5 Ml Each; Insulin Degludec, Solution For Injection, 100 Units/Ml, 3 Ml Each; Insulin Glargine And Lixisenatide, Solution For Injection, 100 Units/Ml + 50 Μg/Ml, 3 Ml Each; Insulin Glargine And Lixisenatide, Solution For Injection, 100 Units/Ml + 33 Mcg/Ml, 3 Ml Each

Комунальне некомерційне підприємство Львівське територіальне медичне об'єднання Клінічна лікарня планового лікування, реабілітації та паліативної допомоги Ukraine has Released a tender for Insulin Glulisine, Solution For Injection, 100 Units/Ml, 3 Ml Each; Insulin Glargine, Solution For Injection, 100 Units/Ml, 3 Ml Each; Insulin Degludec And Liraglutide, Solution For Injection, 100 Units/Ml And 3.6 Mg/Ml, 3 Ml Each; Insulin Detemir, Solution For Injection, 100 Units/Ml, 3 Ml Each; Insulin Aspart (Fast-Acting), Solution For Injection, 100 U/Ml, 3 Ml Each; Insulin Glargine, Solution For Injection, 300 Units/Ml, 1.5 Ml Each; Insulin Degludec, Solution For Injection, 100 Units/Ml, 3 Ml Each; Insulin Glargine And Lixisenatide, Solution For Injection, 100 Units/Ml + 50 Μg/Ml, 3 Ml Each; Insulin Glargine And Lixisenatide, Solution For Injection, 100 Units/Ml + 33 Mcg/Ml, 3 Ml Each in Pharmaceuticals. The tender was released on May 27, 2024.

Country - Ukraine

Summary - Insulin Glulisine, Solution For Injection, 100 Units/Ml, 3 Ml Each; Insulin Glargine, Solution For Injection, 100 Units/Ml, 3 Ml Each; Insulin Degludec And Liraglutide, Solution For Injection, 100 Units/Ml And 3.6 Mg/Ml, 3 Ml Each; Insulin Detemir, Solution For Injection, 100 Units/Ml, 3 Ml Each; Insulin Aspart (Fast-Acting), Solution For Injection, 100 U/Ml, 3 Ml Each; Insulin Glargine, Solution For Injection, 300 Units/Ml, 1.5 Ml Each; Insulin Degludec, Solution For Injection, 100 Units/Ml, 3 Ml Each; Insulin Glargine And Lixisenatide, Solution For Injection, 100 Units/Ml + 50 Μg/Ml, 3 Ml Each; Insulin Glargine And Lixisenatide, Solution For Injection, 100 Units/Ml + 33 Mcg/Ml, 3 Ml Each

Deadline - May 27, 2025

GT reference number - 82242903

Product classification - Medicinal products for the alimentary tract and metabolism